Advertisement
Screener

Insys Therapeutics, Inc. Operating Cash Flow

Insys Therapeutics, Inc. Operating Cash Flow

Insys Therapeutics, Inc. reported Operating Cash Flow of -$16.66 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2019-05-13

  • Insys Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2019-03-31 was -$16.66M.
  • Insys Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2018-12-31 was -$7.31M.
  • Insys Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2018-09-30 was -$8.62M.
  • Insys Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2018-06-30 was -$22.66M.
  • Insys Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$55.99M.
  • Insys Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2017 was -$60.66M, a 202.98% decline from fiscal 2016.
  • Insys Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2016 was $58.90M, a 41.59% decline from fiscal 2015.
  • Insys Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2015 was $100.85M, a 103.06% increase from fiscal 2014.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2019-03-31-$16.66M
10-Q · filed 2019-05-13
-$23.97M
derived: sum of 2 quarters · filed 2019-05-13
-$32.59M
derived: sum of 3 quarters · filed 2019-05-13
-$55.24M
derived: sum of 4 quarters · filed 2019-05-13
2018-12-31-$7.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$15.93M
derived: sum of 2 quarters · filed 2019-03-13
-$38.59M
derived: sum of 3 quarters · filed 2019-03-13
-$55.99M
10-K · filed 2019-03-13
2018-09-30-$8.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$31.28M
derived: sum of 2 quarters · filed 2018-11-09
-$48.68M
10-Q · filed 2018-11-09
-$59.96M
derived: sum of 4 quarters · filed 2019-05-13
2018-06-30-$22.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$40.06M
10-Q · filed 2018-08-09
-$51.34M
derived: sum of 3 quarters · filed 2019-05-13
-$73.48M
derived: sum of 4 quarters · filed 2019-05-13
2018-03-31-$17.40M
10-Q · filed 2019-05-13
-$28.68M
derived: sum of 2 quarters · filed 2019-05-13
-$50.82M
derived: sum of 3 quarters · filed 2019-05-13
2017-12-31-$11.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$33.41M
derived: sum of 2 quarters · filed 2019-03-13
-$60.66M
10-K · filed 2019-03-13
2017-09-30-$22.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$49.38M
10-Q · filed 2018-11-09
2017-06-30-$27.25M
10-Q · filed 2018-08-09
2016-12-31$58.90M
10-K · filed 2019-03-13
2016-06-30-$3.99M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-04-07
$8.32M
10-Q/A · filed 2017-04-07
$9.01M
10-Q · filed 2016-08-05
$34.44M
derived: sum of 3 quarters · filed 2017-04-07
$76.60M
derived: sum of 4 quarters · filed 2017-04-07
2016-03-31$12.31M
10-Q/A · filed 2017-04-07
$12.29M
10-Q · filed 2016-05-05
$38.43M
derived: sum of 2 quarters · filed 2017-04-07
$80.59M
derived: sum of 3 quarters · filed 2017-04-07
$96.31M
derived: sum of 4 quarters · filed 2017-04-07
2015-12-31$26.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$68.27M
derived: sum of 2 quarters · filed 2016-02-29
$84.00M
derived: sum of 3 quarters · filed 2017-04-07
$100.85M
10-K · filed 2016-02-29
2015-09-30$42.16M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2015-11-05
$57.88M
derived: sum of 2 quarters · filed 2017-04-07
$74.73M
10-Q · filed 2015-11-05
$90.61M
derived: sum of 4 quarters · filed 2017-04-07
2015-06-30$15.72M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-04-07
$32.58M
10-Q/A · filed 2017-04-07
$32.09M
10-Q · filed 2015-08-06
$48.46M
derived: sum of 3 quarters · filed 2017-04-07
$61.05M
derived: sum of 4 quarters · filed 2017-04-07
2015-03-31$16.85M
10-Q/A · filed 2017-04-07
$16.19M
10-Q · filed 2015-05-11
$32.73M
derived: sum of 2 quarters · filed 2017-04-07
$45.33M
derived: sum of 3 quarters · filed 2017-04-07
$59.75M
derived: sum of 4 quarters · filed 2017-04-07
2014-12-31$15.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$28.48M
derived: sum of 2 quarters · filed 2016-02-29
$42.90M
derived: sum of 3 quarters · filed 2016-02-29
$49.66M
10-K · filed 2016-02-29
2014-09-30$12.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$27.02M
derived: sum of 2 quarters · filed 2015-11-05
$33.78M
10-Q · filed 2015-11-05
$44.19M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$14.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$21.18M
10-Q · filed 2015-08-06
$31.59M
derived: sum of 3 quarters · filed 2016-02-29
$42.45M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$6.76M
10-Q · filed 2015-05-11
$17.17M
derived: sum of 2 quarters · filed 2016-02-29
$28.03M
derived: sum of 3 quarters · filed 2016-02-29
$30.08M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$10.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$21.26M
derived: sum of 2 quarters · filed 2016-02-29
$23.32M
derived: sum of 3 quarters · filed 2016-02-29
$24.25M
10-K · filed 2016-02-29
2013-09-30$10.85M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$12.91M
derived: sum of 2 quarters · filed 2014-11-12
$13.84M
10-Q · filed 2014-11-12
$11.65M
derived: sum of 4 quarters · filed 2014-11-12
2013-06-30$2.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$2.99M
10-Q · filed 2014-08-12
$799.00K
derived: sum of 3 quarters · filed 2014-08-12
$1.27M
derived: sum of 4 quarters · filed 2014-08-12
2013-03-31$930.00K
10-Q · filed 2014-05-14
-$1.26M
derived: sum of 2 quarters · filed 2014-05-14
-$788.00K
derived: sum of 3 quarters · filed 2014-05-14
-$5.43M
derived: sum of 4 quarters · filed 2014-05-14
2012-12-31-$2.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05
-$1.72M
derived: sum of 2 quarters · filed 2014-03-05
-$6.36M
derived: sum of 3 quarters · filed 2014-03-05
-$13.63M
10-K · filed 2014-03-05
2012-09-30$469.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
-$4.17M
derived: sum of 2 quarters · filed 2013-11-12
-$11.44M
10-Q · filed 2013-11-12
2012-06-30-$4.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
-$11.91M
10-Q · filed 2013-08-13
2012-03-31-$7.27M
10-Q · filed 2013-06-05